1. Home
  2. CIX vs AVTX Comparison

CIX vs AVTX Comparison

Compare CIX & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$23.29

Market Cap

291.7M

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$16.33

Market Cap

328.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
AVTX
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.7M
328.4M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
CIX
AVTX
Price
$23.29
$16.33
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$40.57
AVG Volume (30 Days)
1.7K
2.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
9.48%
N/A
EPS Growth
17.04
72.07
EPS
0.48
N/A
Revenue
$158,285,000.00
$27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.14
N/A
Revenue Growth
8.46
2312.27
52 Week Low
$20.29
$3.43
52 Week High
$32.30
$24.27

Technical Indicators

Market Signals
Indicator
CIX
AVTX
Relative Strength Index (RSI) 49.05 47.84
Support Level $22.86 $13.70
Resistance Level $23.36 $19.39
Average True Range (ATR) 0.47 1.95
MACD -0.07 -0.29
Stochastic Oscillator 35.40 29.77

Price Performance

Historical Comparison
CIX
AVTX

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: